arrow
C

Charles Catton

University Health Network
H指数:78
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) − a phase 2 study: acute safety and quality of life outcomes

高危前列腺癌中盆腔放射治疗联合适当中分割剂量加强照射前列腺(MOB-RT)的Ⅱ期研究:急性安全性和生活质量结果

2026-05-230
PRE
A Comparative Study of Sequential Boost Versus Simultaneous Integrated Boost Radiation Therapy in Postoperative Treatment of Extremity and Trunk Wall Soft Tissue Sarcoma

四肢及躯干壁软组织肉瘤术后治疗中序贯推量照射与同步整合推量放疗的对比研究

2025-11-260
PRE
Stereotactic body radiotherapy for renal tumors: a prospective phase 2 clinical trial

立体定向体部放射治疗肾肿瘤:一项前瞻性二期临床试验

2025-11-230
OAAI
Refining surveillance in Myxoid liposarcoma: long-term recurrence patterns and functional outcomes after surgery ± radiotherapy in 186 patients

黏液脂肪肉瘤的随访优化:186例术后±放疗的长期复发模式及功能结局

2025-11-210
PRE
Correction: Cumulative incidence and survival outcomes of brain metastases in sarcoma: a large single center retrospective analysis

更正:软组织肉瘤脑转移的累积发病率和生存结局:一项大型单中心回顾性分析

2025-10-160
PRE
Reduction of Bone Fracture after Radiotherapy in Lower Extremity Soft Tissue Sarcoma after Implementing Bone Avoidance Objectives for Radiotherapy Planning

在实施放射治疗计划中规避骨目标的措施后,下肢软组织肉瘤放疗后骨折的减少

2025-10-140
PRE
Outcomes of local therapies for recurrent and radiation-associated soft tissue sarcomas of the extremities and trunk: is there a role for re-irradiation?

四肢和躯干复发及放射性相关软组织肉瘤局部治疗的结局:是否应考虑再放疗?

2025-09-100
PRE
Preoperative intensity-modulated radiation therapy in lower extremity soft tissue sarcomas with and without dose avoidance of uninvolved skin/subcutaneous tissue

术前调强放射治疗在下肢软组织肉瘤中的应用:含与不含未受累皮肤/皮下组织的剂量规避

Cancer
IF5.1
2025-09-050
OAAI
The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trial

立体定向体部放射治疗在寡进展性前列腺癌中的作用:一项针对前瞻性、II期RADIANT试验的部位特异性分析

2025-07-080
OA
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data

非转移性前列腺癌术后放疗 (DADSPORT) 的雄激素抑制持续时间: 一项协作系统评价和汇总数据的荟萃分析

2025-06-260
OAAI
Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer

Pro益中患者报告的生活质量,一项3期随机临床试验,评估中度大分割放疗治疗中危前列腺癌

2025-05-060
PRE
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)

根治性前列腺切除术后无,短期或长期雄激素剥夺疗法与术后放疗的随机试验: radical-hd的三向比较结果 (NCT00541047)

2024-11-011
OA
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)

根治性前列腺切除术 (RP) 后放疗 (RT) 的时机: radical-rt试验 (NCT00541047) 的长期结果

2024-07-019
OAAI
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

在前列腺癌术后放疗中增加6个月的雄激素剥夺疗法: radical-hd随机对照试验中短程与无雄激素剥夺疗法的比较

LANCET
IF88.5
2024-06-0114
OAAI
Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study

放射诱导肉瘤 (RIS) 的临床人口统计学特征和结果: CanSaRCC研究

2023-09-282
OAAI
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer
2022-11-0114
PRE
RADICALS-HD: Reflections before the Results are Known
2022-09-016
OAAI